D. Flentje

412 total citations
13 papers, 339 citations indexed

About

D. Flentje is a scholar working on Oncology, Molecular Biology and Nephrology. According to data from OpenAlex, D. Flentje has authored 13 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Nephrology. Recurrent topics in D. Flentje's work include Parathyroid Disorders and Treatments (5 papers), Cancer Cells and Metastasis (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). D. Flentje is often cited by papers focused on Parathyroid Disorders and Treatments (5 papers), Cancer Cells and Metastasis (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). D. Flentje collaborates with scholars based in Germany and United States. D. Flentje's co-authors include P. Schlag, Stefanie Fischer, E. Blind, Walter Hitzler, H. Schmidt‐Gayk, Stephan Scharla, Stephen A. Sapareto, H. J. Buhr, Gary Van Zant and Christian Herfarth and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Chemistry and British journal of surgery.

In The Last Decade

D. Flentje

13 papers receiving 325 citations

Peers

D. Flentje
Dennis A. Laska United States
J.P. Cruse United Kingdom
Connor Francis United States
Archana Raman United States
E. S. Olesen Denmark
Yuen Fei Wong United Kingdom
Han-Gyul Yoo United States
Dennis A. Laska United States
D. Flentje
Citations per year, relative to D. Flentje D. Flentje (= 1×) peers Dennis A. Laska

Countries citing papers authored by D. Flentje

Since Specialization
Citations

This map shows the geographic impact of D. Flentje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Flentje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Flentje more than expected).

Fields of papers citing papers by D. Flentje

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Flentje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Flentje. The network helps show where D. Flentje may publish in the future.

Co-authorship network of co-authors of D. Flentje

This figure shows the co-authorship network connecting the top 25 collaborators of D. Flentje. A scholar is included among the top collaborators of D. Flentje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Flentje. D. Flentje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Buhr, HJ, D. Flentje, Stefanie Fischer, & Christian Herfarth. (1990). [Clinical management of persistent primary hyperparathyroidism].. PubMed. 987–90. 1 indexed citations
2.
Fischer, Stefanie, et al.. (1990). Intraoperative and postoperative PTH secretion mode in patients with hyperparathyroidism. World Journal of Surgery. 14(3). 349–353. 24 indexed citations
3.
Flentje, D., H Schmidt-Gayk, Stefanie Fischer, et al.. (1990). Intact parathyroid hormone in primary hyperparathyroidism. British journal of surgery. 77(2). 168–172. 27 indexed citations
5.
Blind, E., H. Schmidt‐Gayk, Stephan Scharla, et al.. (1988). Two-Site Assay of Intact Parathyroid Hormone in the Investigation of Primary Hyperparathyroidism and Other Disorders of Calcium Metabolism Compared With a Midregion Assay*. The Journal of Clinical Endocrinology & Metabolism. 67(2). 353–360. 91 indexed citations
6.
Flentje, D., et al.. (1987). Does in vitro colony formation and chemosensitivity relate to DNA ploidy and S-phase fractions?. Journal of Cancer Research and Clinical Oncology. 113(1). 87–90. 2 indexed citations
7.
Flentje, Michael, D. Flentje, & P. Schlag. (1986). Comparison of 5-FU versus FUDR activity in human colorectal cancer using an in vitro clonogenic assay (HTCA). Cancer Chemotherapy and Pharmacology. 18(3). 223–5. 5 indexed citations
8.
Flentje, D. & P. M. Schlag. (1985). Is chemosensitivity testing for peri-operative treatment planning in gastro-intestinal cancer by the human tumour colony assay worthwhile?. PubMed. 11(3). 227–33. 4 indexed citations
9.
Flentje, D., et al.. (1984). Differential effect of hyperthermia on murine bone marrow normal colony-forming units and AKR and L1210 leukemia stem cells.. PubMed. 44(5). 1761–6. 26 indexed citations
10.
Flentje, D., et al.. (1984). Analysis of Mopc‐315 Plasmacytoma By Elutriation and Flow Cytometry. Cell Proliferation. 17(2). 171–183. 2 indexed citations
11.
Valeriote, Frederick A., et al.. (1984). Potentiation by amphotericin B of the cytotoxicity of anticancer agents against MOPC-315 plasmacytoma and lewis lung carcinoma. Cancer Chemotherapy and Pharmacology. 13(2). 126–30. 4 indexed citations
12.
Schlag, P. & D. Flentje. (1984). Chemosensitivity testing of human neoplasms using the soft agar colony assay. Cancer Treatment Reviews. 11. 131–137. 128 indexed citations
13.
Zant, Gary Van, et al.. (1983). The Effect of Hyperthermia on Hemopoietic Progenitor Cells of the Mouse. Radiation Research. 95(1). 142–142. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026